Document is current
Any future updates will be listed below
-
Authors
Madhavan, Ashwin
Rogers, Sophie L.
Bosco, Julian J.
Ross, Laura
Samalia, Priya D.
Hall, Anthony J.
Lim, Lyndell L.
-
Funding
Funding for this research was provided by:
Centre for Eye Research Australia (Centre for Eye Research Australia (CERA) receives infrastructure funding from the Victorian Government.)
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 12 December 2025
First Online: 25 December 2025
Declarations
:
: This study was approved by the Royal Victorian Eye and Ear Hospital Human Research Ethics Committee (reference number 22/1557HL) and was conducted in adherence with the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients.
: Written informed consent for participation in the study was obtained from all participants. This manuscript does not contain any individual person’s details.
: AM: No competing interests; SLR: No competing interests; JJB: No competing interests; LR: Grant funding from Australian Rheumatology Association, University of Melbourne, SCTC Working Group; PDS: No competing interests; AJH: Advisory board (AbbVie), Consulting fees (Roche, Novartis and UCB); LLL: Grants (Bayer, Roche), Consultant (Bayer, Roche, Novotech), Payment/honoraria (Roche, Novartis, Bayer), Executive Board Member of International Ocular Inflammation Society (unpaid).
